{
  "schema_version": "0.1.0",
  "case_id": "HR-EN001",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "EN001",
    "display_name": "John Locke",
    "aliases": [],
    "historical_mentions": [
      "HR-EN011"
    ],
    "sex": "male",
    "era": "Enlightenment",
    "nationality": "English",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1632-09-08",
          "display": "8 September 1632 (Gregorian; 29 August 1632, Julian)",
          "precision": "day",
          "calendar": "proleptic_gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1632-08-29",
              "display": "29 August 1632 (Julian)",
              "precision": "day",
              "calendar": "julian"
            },
            "source_ids": [
              "SRC-0002",
              "SRC-0005"
            ],
            "resolution_status": "superseded",
            "note": "The date in the sources, in the Julian calendar then used in England; the same day is 8 September 1632 in the Gregorian calendar, which the record uses for true-frame dates."
          },
          {
            "date": {
              "iso": "1632",
              "display": "1632",
              "precision": "year",
              "calendar": "proleptic_gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1704-11-08",
          "display": "8 November 1704 (Gregorian; 28 October 1704, Julian)",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1704-10-28",
              "display": "28 October 1704 (Julian)",
              "precision": "day",
              "calendar": "julian"
            },
            "source_ids": [
              "SRC-0001",
              "SRC-0002",
              "SRC-0005"
            ],
            "resolution_status": "superseded",
            "note": "The date in the sources, in the Julian calendar; after February 1700 the difference was eleven days, so the same day is 8 November 1704 in the Gregorian calendar."
          },
          {
            "date": {
              "iso": "1704",
              "display": "1704",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-EN001-SYN",
      "ssn": "000-01-8305",
      "date_of_birth": "1966-09-08",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Prudence Hartwell-Osei, MD",
      "fictional_consultant": {
        "name": "Ambrose Nwankwo-Fairfax, MD",
        "specialty": "Pulmonology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1632-09-08",
        "display": "8 September 1632 (29 August 1632, Julian)",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born at Wrington, Somerset.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1652",
        "display": "1652",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Elected to a studentship at Christ Church, Oxford; BA 1656; medical studies follow.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1661-02-23",
        "display": "23 February 1661 (13 February 1660/1, Julian)",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "His father dies, of consumption or a kindred malady by his biographer's account; his brother dies of consumption soon after.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1667",
        "display": "1667",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Physician in Lord Ashley's household; friendship with Sydenham; the abscess operation of June 1668.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1670",
        "display": "About 1670",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "A cough begins that troubles him for the rest of his life.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1675",
        "display": "1675",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Bachelor of Medicine (February 1674/5); in France, mostly at Montpellier, from late 1675 to 1677.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1679",
        "display": "1679",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Back in London, he must leave the city often, and always in winter, because of its coal smoke.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1683",
        "display": "1683 to 1689",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Political exile in Holland; returns in February 1689.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1691",
        "display": "Spring 1691",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Settles at Oates, High Laver, Essex.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1692-03-10",
        "display": "10 March 1692 (29 February 1691/2, Julian)",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Writes that his lungs cannot bear the smoke of the city.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1692-05",
        "display": "May 1692",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Visits Cambridge at a friend's invitation.",
      "claim_ids": [
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1692-12-08",
        "display": "8 December 1692 (28 November 1692, Julian)",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Back at Oates after a day in London left him hardly able to breathe.",
      "claim_ids": [
        "CLM-0013"
      ]
    },
    {
      "event_id": "EVT-0013",
      "date": {
        "iso": "1696",
        "display": "1696 to 1700",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Board of Trade: in London only in the warmer months.",
      "claim_ids": [
        "CLM-0014"
      ]
    },
    {
      "event_id": "EVT-0014",
      "date": {
        "iso": "1698-02-02",
        "display": "2 February 1698 (23 January 1697/8, Julian)",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Breathless lying flat during a winter visit to London.",
      "claim_ids": [
        "CLM-0015"
      ]
    },
    {
      "event_id": "EVT-0015",
      "date": {
        "iso": "1700",
        "display": "1700 to 1702",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Sore legs keep him in bed; deafness for a time.",
      "claim_ids": [
        "CLM-0016"
      ]
    },
    {
      "event_id": "EVT-0016",
      "date": {
        "iso": "1704-11-08",
        "display": "8 November 1704 (28 October 1704, Julian)",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at Oates, aged 72, after a year of increasing breathlessness and leg swelling.",
      "claim_ids": [
        "CLM-0017"
      ]
    },
    {
      "event_id": "EVT-0017",
      "date": {
        "iso": "1876",
        "display": "1876 to 2022",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Biographers and historians describe his illness as a lifelong cough, possible consumption, and asthma.",
      "claim_ids": [
        "CLM-0018",
        "CLM-0019"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "John Locke was born on 29 August 1632 (Julian; 8 September 1632, Gregorian) at Wrington, Somerset, to Puritan parents of modest means. His father, John Locke (1606 to 1661), was a country attorney who served in a cavalry company on the Parliamentary side early in the Civil War; his mother was Agnes Keene. He had one brother, Thomas, born in 1637.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "He was educated at Westminster School and at Christ Church, Oxford, where he was elected to a studentship in 1652 and took his BA in 1656.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Westminster entry is dated 1646 in one source and 1647 in another; the record gives no year.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "His father died on 13 February 1660/1 (Julian), at about 54, of consumption or some kindred malady, by his biographer's account; his only brother, Thomas, died of consumption soon afterwards, at about 26, leaving no children.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "A nineteenth-century biographer's account; 'consumption' then meant a wasting chest disease, usually but not always tuberculosis.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Vol. 1, chapters 2 and 5"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "He studied medicine at Oxford and took the degree of Bachelor of Medicine in February 1674/5, with a licence to practise, but never took the doctorate. From 1667 he lived in the household of Lord Ashley (later the first Earl of Shaftesbury) as his physician, and in June 1668 he organized the surgical drainage of a large abscess above Ashley's liver, with advice from leading physicians including Thomas Sydenham.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "DNB dates the degree to 1674 and Williams to 6 February 1675; under the English year that began on 25 March these are the same day.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "From about 1667 he was a close friend of the physician Thomas Sydenham, accompanied him on visits to patients, helped him with his writings, and was praised by him; Sydenham embraced careful observation of disease.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "His biographer H. R. Fox Bourne wrote that about 1670 Locke began to have a cough that seriously troubled him through the remainder of his life, and that an undated fragment in his hand from those years, titled 'Tussis', was the start of a paper on coughs. His health was already weak by the early 1670s; a letter from Sydenham, probably at the end of 1674, advised him to go to bed early and be very temperate and cautious, and from late 1675 to 1677 he lived in France, mostly at Montpellier, then much visited by invalids.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The onset of a lifelong cough in his late thirties is documented; its cause is not.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Vol. 1, chapter 5"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Lady Masham later wrote that although his travels in France had done his health some good, after his return he was still less able than before to stay long in London without retreating to a neighbouring village 'to recover the prejudice his health received from the smoke of that vast quantity of sea-coal which is burnt in this great city'. From then on he left London as often as he could, and always in the winter months.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "A close friend's account, written after his death, linking his illness to London's coal smoke.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Vol. 1, chapter 8, quoting Lady Masham to Le Clerc, 12 January 1704/5"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Among his medical papers, an account of consumption that Fox Bourne describes as drawn from Sydenham's observation and confirmed by Locke attributes the frequency of consumptions in London to 'a perpetual mist' mixed with the fumes of the city's trades, 'but especially the sulphur and fumes of sea coals, with which the air is repleted; and these being sucked into our lungs ... give an occasion to a cough'.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Seventeenth-century medical theory, recorded as such; it shows that he and Sydenham linked coal smoke with cough.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Vol. 1, chapter 8, 'Extracts of Sydenham's Physic Books'"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "He left England in the autumn of 1683, when he was under suspicion for his association with Shaftesbury, lived in Holland, and landed at Greenwich on 12 February 1688/9 (Julian). He soon declined a diplomatic mission on the ground of insufficient health, and wrote in April 1689 that he hoped to breathe more easily and be less troubled by his cough.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His exile was political; the sources read do not say that he went to Holland for his health.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 10, Locke to Limborch, 12 April 1689"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "He found the smoke of London unfavourable to his health, and from the spring of 1691 lived at Oates, in the parish of High Laver, Essex, the home of Sir Francis and Lady Masham (Damaris Cudworth).",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "On 29 February 1691/2 (Julian; 10 March 1692, Gregorian) he wrote to Philipp van Limborch that since visiting Robert Boyle on his deathbed in December, 'my health has kept me in the country, for I found my lungs could not bear the smoke of the city'.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own words, in Fox Bourne's translation of the Latin letter.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 12, Locke to Limborch, 29 February 1691-2"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "In May 1692 he spent a day or two at Cambridge after Isaac Newton wrote to him on 3 May (Julian) that, now the churlish weather was almost over, he hoped to see him there.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 12, Newton to Locke, 3 May 1692"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0013",
      "statement": "In November 1692 he wrote that after a single day in London he fell so ill that he could hardly breathe and had to come away; back at Oates on 28 November (Julian) he told Edward Clarke, 'well I cannot say I yet am, under so troublesome a cough as I have, but my lungs move easier than they did'.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own account of breathlessness in London relieved in the country.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 12, Locke to Limborch and to Clarke, 28 November 1692"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "As a commissioner of the Board of Trade from 1696 to 1700 he suffered so much from his chest illness, which the Stanford Encyclopedia calls asthma, that he could bear the smoke of London only in the four warmer months; he attended its meetings in the summer and autumn and was confined to Oates the rest of the year. In October 1698 he wrote that 'a troublesome cough and great difficulty of breathing' were forcing him out of town.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 14, Locke to Limborch, 18 October 1698"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0015",
      "statement": "Summoned to London to see the king on 23 January 1697/8 (Julian), he wrote to Lord Somers that when he lay down in bed his breath failed him, so that he had to sit up most of the night and at three in the morning got up and sat by the fire till morning; he returned to Oates at once, and declined the employment offered because of his health.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own description of breathlessness lying flat during a winter visit to London.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 13, Locke to Somers"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0016",
      "statement": "From 1700 he was often kept in bed by sore legs and wrote of 'my old evil of my breast'; by 1702 he had become so deaf for a time that he could hardly take part in conversation.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 15"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0017",
      "statement": "In June 1704 he wrote that his shortness of breath and uneasiness increased every day, despite the season that usually restored him. That summer his legs swelled, more so towards the end of October. Lady Masham wrote that all the faculties of his mind were perfect to the last, and that he died of weakness alone. On 28 October 1704 (Julian; 8 November 1704, Gregorian), carried to his chair while she read the psalms to him, he died quietly at Oates, aged 72. He was buried in the churchyard at High Laver.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented decline of his last year: increasing breathlessness, leg swelling, and weakness; no cause of death was recorded.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Vol. 2, chapter 15, Locke to King, 1 June 1704; Le Clerc's eloge; Lady Masham"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0018",
      "statement": "Modern accounts describe him as asthmatic: the Stanford Encyclopedia of Philosophy states that he was asthmatic, and a 2006 history of medicine article that his health was blighted throughout life by asthma, which often incapacitated him for long periods.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "A retrospective label in modern secondary sources; no physician's diagnosis from his lifetime is recorded.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0019",
      "statement": "Fox Bourne judged that his cough was connected with disease in the lungs, and that probably only extreme care in treating himself had kept it from passing into a rapid consumption.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "A nineteenth-century biographer's interpretation. No source read diagnoses tuberculosis; his long survival argues against it.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Vol. 1, chapters 5 and 8"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Uzgalis W. John Locke. The Stanford Encyclopedia of Philosophy (substantive revision 7 July 2022)",
      "publisher": "Stanford Encyclopedia of Philosophy, Stanford University",
      "url": "https://plato.stanford.edu/entries/locke/",
      "source_type": "scholarly",
      "published": "2022",
      "accessed": "2026-11-06",
      "rights_note": "Scholarly encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Stephen L. Locke, John (1632-1704). Dictionary of National Biography, vol. 34 (London, 1893)",
      "publisher": "Wikisource",
      "url": "https://en.wikisource.org/wiki/Dictionary_of_National_Biography,_1885-1900/Locke,_John_(1632-1704)",
      "source_type": "scholarly",
      "published": "1893",
      "accessed": "2026-11-06",
      "rights_note": "Public-domain reference work; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Fox Bourne HR. The Life of John Locke, vol. 1 (London: Henry S. King, 1876)",
      "publisher": "Internet Archive",
      "url": "https://archive.org/details/lifeofjohnlocke01bouruoft",
      "source_type": "primary",
      "published": "1876",
      "accessed": "2026-11-06",
      "rights_note": "Public-domain biography quoting Locke's papers and Lady Masham's letter; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Fox Bourne HR. The Life of John Locke, vol. 2 (London: Henry S. King, 1876)",
      "publisher": "Internet Archive",
      "url": "https://archive.org/details/lifeofjohnlocke02bouruoft",
      "source_type": "primary",
      "published": "1876",
      "accessed": "2026-11-06",
      "rights_note": "Public-domain biography quoting Locke's letters; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Williams AN. Physician, philosopher, and paediatrician: John Locke's practice of child health care. Arch Dis Child 2006;91(1):85-89. PMID 16371386",
      "publisher": "PubMed Central",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2083071/",
      "source_type": "scholarly",
      "published": "2006",
      "accessed": "2026-11-06",
      "rights_note": "Peer-reviewed article; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Anstey PR, Principe LM. John Locke and the case of Anthony Ashley Cooper. Early Sci Med 2011;16(5):379-503. PMID 22332471",
      "publisher": "PubMed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/22332471/",
      "source_type": "scholarly",
      "published": "2011",
      "accessed": "2026-11-06",
      "rights_note": "Abstract; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Longstaff A. Calendars from around the world",
      "publisher": "Royal Museums Greenwich",
      "url": "https://www.rmg.co.uk/sites/default/files/Calendars-from-around-the-world.pdf",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Museum education paper on the Julian and Gregorian calendars; used for the calendar conversion."
    },
    {
      "source_id": "SRC-0008",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-06",
      "accessed": "2026-11-06",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-12",
    "index_age": 59,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Evaluate a 59-year-old never-smoker with a lifelong cough, wheeze, and breathlessness, worse in city air and by open fires at home: pre- and post-bronchodilator spirometry interpreted with race-neutral GLI equations and the ATS/ERS 2022 bronchodilator criterion, FeNO, blood eosinophils and IgE, DLCO, alpha-1 antitrypsin, NT-proBNP, an interferon-gamma release assay, chest X-ray, and CT for persistent airflow limitation; a reasoned decision between asthma with persistent airflow limitation and COPD from non-tobacco exposures (GINA 2025, GOLD 2025); GINA track 1 budesonide-formoterol maintenance-and-reliever therapy with add-on tiotropium; inhaler technique, adherence, and a written action plan with peak-flow zones; pulmonary rehabilitation; air pollution as a cause and exposure reduction (WHO 2021 air quality guidelines, air quality alerts, removing indoor solid-fuel smoke, HEPA air cleaning, respirators on unavoidable high-pollution days); vaccinations; and management of a viral flare by the action plan (CMID asthma and COPD monographs).",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-12",
        "purpose": "Primary care visit for a lifelong cough with wheeze and breathlessness, worse in city air and by open fires, in a never-smoker"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-26",
        "purpose": "Two-week review of lung function and blood tests, diagnosis, start of treatment, and pulmonology consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-06-18",
        "purpose": "Twelve-week asthma review with repeat spirometry after pulmonary rehabilitation"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-09-17",
        "purpose": "Preventive health visit at 60"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-10-08",
        "purpose": "Same-day sick visit for a cold with a yellow-zone asthma flare"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-10-22",
        "purpose": "Asthma review two weeks after a cold with a yellow-zone flare"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Chronic cough with wheeze and breathlessness since his late thirties, worse every winter and within a day of any stay in the city or by an open fire, better in warm weather and country air; night cough two or three times a week this winter; under evaluation",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R05.3",
            "display": "Chronic cough",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting problem echoing his documented lifelong cough and breathlessness in London's coal smoke; superseded by the diagnosis at the second visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-26"
      },
      {
        "id": "PRB-002",
        "display": "Long exposure to urban air pollution (decades in a large city with heavy traffic and coal and wood burning) and to indoor solid-fuel smoke from open coal and wood fires at home",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z77.110",
            "display": "Contact with and (suspected) exposure to air pollution",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern exposure echoing the coal smoke that he, Sydenham, and Lady Masham blamed for his cough; no historical level of exposure is asserted.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-003",
        "display": "Asthma with persistent airflow limitation, type 2 (eosinophilic) phenotype, in a never-smoker: post-bronchodilator FEV1/FVC 0.62, FEV1 62 percent predicted rising 380 mL after albuterol, FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, IgE 186 IU/mL, normal DLCO, no emphysema on CT; aggravated by air pollution and indoor smoke; not COPD",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J45.40",
            "display": "Moderate persistent asthma, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0011",
            "CLM-0018"
          ],
          "synthetic_reason": "Synthetic modern diagnosis. His lifelong cough and breathlessness worse in coal smoke are documented (D); calling them asthma is a modern retrospective reading (R).",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-03-26"
      },
      {
        "id": "PRB-004",
        "display": "Acute viral upper respiratory infection (common cold) with a yellow-zone asthma flare: peak flow 68 percent of personal best, managed with extra as-needed budesonide-formoterol by his action plan, without oral corticosteroids; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J06.9",
            "display": "Acute upper respiratory infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic intercurrent illness at an unscheduled visit; it echoes, without asserting, his documented autumn chest troubles (CLM-0014).",
          "author": "The Human Record generator",
          "created": "2026-11-06T10:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-10-08",
        "abatement_date": "2026-10-22"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Albuterol 90 mcg/actuation inhaler, two puffs every 4 hours as needed while tests are done; hold for 6 hours before spirometry",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2123076",
            "display": "NDA020983 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "{puff}"
        },
        "route": "inhalation",
        "frequency": {
          "period": 4,
          "period_unit": "h",
          "text": "Two puffs every 4 hours as needed"
        },
        "start_date": "2026-03-12",
        "end_date": "2026-03-26",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic short-acting reliever for two weeks while the diagnosis is confirmed, so that the bronchodilator response is measured before any inhaled corticosteroid.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "as_needed": true
      },
      {
        "id": "MED-002",
        "display": "Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 4): two inhalations twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1246304",
            "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "{inhalation}"
        },
        "route": "inhalation",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "Two inhalations twice daily plus one as needed; no more than 12 a day"
        },
        "start_date": "2026-03-26",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0011",
            "CLM-0018"
          ],
          "synthetic_reason": "Synthetic medium-dose inhaled corticosteroid-formoterol maintenance-and-reliever therapy, replacing albuterol, chosen for poorly controlled asthma with low lung function.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Tiotropium 2.5 mcg/actuation soft-mist inhaler, two inhalations once daily (add-on long-acting muscarinic antagonist, GINA step 5)",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1552002",
            "display": "60 ACTUAT tiotropium 0.0025 MG/ACTUAT Inhalation Spray",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "{inhalation}"
        },
        "route": "inhalation",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two inhalations once a day"
        },
        "start_date": "2026-06-18",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic add-on LAMA for persistent symptoms and persistent airflow limitation despite good adherence and technique on medium-dose ICS-formoterol.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for aches or fever, no more than 3 g a day",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "One or two tablets every 6 hours as needed; no more than six tablets a day"
        },
        "start_date": "2026-10-08",
        "end_date": "2026-10-22",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic analgesic for a cold.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "as_needed": true
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-ACT-V1",
        "display": "Total score [ACT]",
        "label": "Asthma Control Test",
        "status": "final",
        "effective_date": "2026-03-12",
        "value": 12,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82668-5",
            "display": "Total score [ACT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic Asthma Control Test at presentation: very poorly controlled symptoms (19 or less is not well controlled; 15 or less very poorly controlled).",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-03-12",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-2 at presentation, part of comorbidity screening; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 14.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count with differential; eosinophils 0.46 x 10^3/uL, within the laboratory range but at a level typical of type 2 airway inflammation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White blood cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 7.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 3.4,
          "high": 9.6
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count with differential; eosinophils 0.46 x 10^3/uL, within the laboratory range but at a level typical of type 2 airway inflammation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-EOS-V1",
        "display": "Eosinophils [#/volume] in Blood by Automated count",
        "label": "Blood eosinophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 0.46,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 0.0,
          "high": 0.5,
          "text": "0.15 or more suggests type 2 airway inflammation; 0.30 or more is typical of it"
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "711-2",
            "display": "Eosinophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count with differential; eosinophils 0.46 x 10^3/uL, within the laboratory range but at a level typical of type 2 airway inflammation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 251,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count with differential; eosinophils 0.46 x 10^3/uL, within the laboratory range but at a level typical of type 2 airway inflammation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGE-V1",
        "display": "IgE [Units/volume] in Serum or Plasma",
        "label": "Total IgE",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 186,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 100
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19113-0",
            "display": "IgE [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic total IgE, raised.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AAT-V1",
        "display": "Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma",
        "label": "Alpha-1 antitrypsin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 131,
        "unit": "mg/dL",
        "reference_range": {
          "low": 90,
          "high": 200
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1825-9",
            "display": "Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alpha-1 antitrypsin level, normal; deficiency excluded as a cause of persistent airflow limitation in a never-smoker.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-NTBNP-V1",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 58,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125,
          "text": "Below 125 pg/mL makes heart failure unlikely in an outpatient"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic NT-proBNP, normal; heart failure unlikely as a cause of breathlessness.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-IGRA-V1",
        "display": "Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood",
        "label": "Interferon-gamma release assay (TB1 antigen minus nil)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-12",
        "value": 0.02,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 0.34,
          "text": "Positive at 0.35 IU/mL or more"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "64084-7",
            "display": "Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic interferon-gamma release assay, negative; ordered because of a chronic cough and a family history of consumption.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1PRE-V2",
        "display": "FEV1 --pre bronchodilation",
        "label": "FEV1 before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 2.11,
        "unit": "L",
        "reference_range": {
          "low": 2.62,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 3.38 L"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20157-4",
            "display": "FEV1 --pre bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FVCPRE-V2",
        "display": "Forced vital capacity [Volume] Respiratory system by Spirometry --pre bronchodilation",
        "label": "FVC before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 3.71,
        "unit": "L",
        "reference_range": {
          "low": 3.46,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 4.37 L"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19876-2",
            "display": "Forced vital capacity [Volume] Respiratory system by Spirometry --pre bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-RATIOPRE-V2",
        "display": "FEV1/FVC",
        "label": "FEV1/FVC before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 0.57,
        "unit": "{ratio}",
        "reference_range": {
          "low": 0.67,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19926-5",
            "display": "FEV1/FVC",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1PCT-V2",
        "display": "FEV1 measured/predicted",
        "label": "FEV1 percent predicted (before bronchodilator)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 62,
        "unit": "%",
        "reference_range": {
          "low": 80,
          "text": "GLI Global race-neutral equations for a man of 59, 178 cm"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20152-5",
            "display": "FEV1 measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1POST-V2",
        "display": "FEV1 --post bronchodilation",
        "label": "FEV1 after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 2.49,
        "unit": "L",
        "reference_range": {
          "low": 2.62,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 3.38 L"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20155-8",
            "display": "FEV1 --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable. Fifteen minutes after albuterol 400 mcg: FEV1 rose 380 mL (18 percent of baseline, 11 percent of predicted), a positive bronchodilator response by the ATS/ERS 2022 criterion of more than 10 percent of predicted; the ratio stays below the lower limit of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FVCPOST-V2",
        "display": "Forced vital capacity [Volume] Respiratory system --post bronchodilation",
        "label": "FVC after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 4.02,
        "unit": "L",
        "reference_range": {
          "low": 3.46,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 4.37 L"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19875-4",
            "display": "Forced vital capacity [Volume] Respiratory system --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable. Fifteen minutes after albuterol 400 mcg: FEV1 rose 380 mL (18 percent of baseline, 11 percent of predicted), a positive bronchodilator response by the ATS/ERS 2022 criterion of more than 10 percent of predicted; the ratio stays below the lower limit of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-RATIOPOST-V2",
        "display": "FEV1/FVC --post bronchodilation",
        "label": "FEV1/FVC after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 0.62,
        "unit": "{ratio}",
        "reference_range": {
          "low": 0.67,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; below it (and below 0.70) after bronchodilator means persistent airflow limitation"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "69970-2",
            "display": "FEV1/FVC --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic spirometry at the pulmonary function laboratory, albuterol withheld for 6 hours beforehand; ATS/ERS acceptable and repeatable. Fifteen minutes after albuterol 400 mcg: FEV1 rose 380 mL (18 percent of baseline, 11 percent of predicted), a positive bronchodilator response by the ATS/ERS 2022 criterion of more than 10 percent of predicted; the ratio stays below the lower limit of normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-DLCO-V2",
        "display": "Diffusion capacity.carbon monoxide",
        "label": "DLCO",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 26.4,
        "unit": "mL/min/mm[Hg]",
        "reference_range": {
          "low": 20.5,
          "text": "Lower limit of normal, GLI 2017 race-neutral equations; predicted 26.9"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19911-7",
            "display": "Diffusion capacity.carbon monoxide",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diffusing capacity, normal; argues against emphysema.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FENO-V2",
        "display": "Fractional concentration of exhaled nitric oxide",
        "label": "FeNO",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 41,
        "unit": "[ppb]",
        "reference_range": {
          "high": 25,
          "text": "In adults, below 25 ppb low, 25 to 50 intermediate, above 50 high (ATS)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "96269-6",
            "display": "Fractional concentration of exhaled nitric oxide",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic FeNO in the intermediate range, measured before any inhaled corticosteroid, supporting eosinophilic (type 2) airway inflammation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-SMWT-V2",
        "display": "Six minute walk test",
        "label": "Six-minute walk distance",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-26",
        "value": 430,
        "unit": "m",
        "reference_range": {
          "low": 480,
          "text": "Predicted about 630 m for his age, sex, height and weight (Enright and Sherrill); lower limit about 480 m"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "64098-7",
            "display": "Six minute walk test",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-minute walk distance before pulmonary rehabilitation, below the lower limit for his age; lowest oxygen saturation 94 percent.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ACT-V2",
        "display": "Total score [ACT]",
        "label": "Asthma Control Test",
        "status": "final",
        "effective_date": "2026-03-26",
        "value": 13,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82668-5",
            "display": "Total score [ACT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Asthma Control Test two weeks after presentation, on albuterol as needed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ACT-V3",
        "display": "Total score [ACT]",
        "label": "Asthma Control Test",
        "status": "final",
        "effective_date": "2026-06-18",
        "value": 19,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82668-5",
            "display": "Total score [ACT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Asthma Control Test after twelve weeks of treatment: better, but not yet well controlled.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1PRE-V3",
        "display": "FEV1 --pre bronchodilation",
        "label": "FEV1 before bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 2.46,
        "unit": "L",
        "reference_range": {
          "low": 2.62,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 3.38 L"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20157-4",
            "display": "FEV1 --pre bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat spirometry twelve weeks after starting inhaled corticosteroid-formoterol.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1PCT-V3",
        "display": "FEV1 measured/predicted",
        "label": "FEV1 percent predicted (before bronchodilator)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 73,
        "unit": "%",
        "reference_range": {
          "low": 80,
          "text": "GLI Global race-neutral equations for a man of 59, 178 cm"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20152-5",
            "display": "FEV1 measured/predicted",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat spirometry twelve weeks after starting inhaled corticosteroid-formoterol.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FEV1POST-V3",
        "display": "FEV1 --post bronchodilation",
        "label": "FEV1 after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 2.58,
        "unit": "L",
        "reference_range": {
          "low": 2.62,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 3.38 L"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20155-8",
            "display": "FEV1 --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat spirometry twelve weeks after starting inhaled corticosteroid-formoterol.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FVCPOST-V3",
        "display": "Forced vital capacity [Volume] Respiratory system --post bronchodilation",
        "label": "FVC after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 4.12,
        "unit": "L",
        "reference_range": {
          "low": 3.46,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; predicted 4.37 L"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19875-4",
            "display": "Forced vital capacity [Volume] Respiratory system --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat spirometry twelve weeks after starting inhaled corticosteroid-formoterol.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-RATIOPOST-V3",
        "display": "FEV1/FVC --post bronchodilation",
        "label": "FEV1/FVC after bronchodilator",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 0.63,
        "unit": "{ratio}",
        "reference_range": {
          "low": 0.67,
          "text": "Lower limit of normal, GLI Global race-neutral equations for a man of 59, 178 cm; below it (and below 0.70) after bronchodilator means persistent airflow limitation"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "69970-2",
            "display": "FEV1/FVC --post bronchodilation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat spirometry twelve weeks after starting inhaled corticosteroid-formoterol. Post-bronchodilator ratio still below the lower limit of normal: persistent airflow limitation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FENO-V3",
        "display": "Fractional concentration of exhaled nitric oxide",
        "label": "FeNO",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 22,
        "unit": "[ppb]",
        "reference_range": {
          "high": 25,
          "text": "In adults, below 25 ppb low, 25 to 50 intermediate, above 50 high (ATS)"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "96269-6",
            "display": "Fractional concentration of exhaled nitric oxide",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic FeNO on treatment, now low, consistent with good adherence and an inhaled-corticosteroid response.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-SMWT-V3",
        "display": "Six minute walk test",
        "label": "Six-minute walk distance",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-06-18",
        "value": 505,
        "unit": "m",
        "reference_range": {
          "low": 480,
          "text": "Predicted about 630 m for his age, sex, height and weight (Enright and Sherrill); lower limit about 480 m"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "64098-7",
            "display": "Six minute walk test",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-minute walk distance after eight weeks of pulmonary rehabilitation: 75 m better, more than the minimal important difference of about 30 m.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-PREV",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-17",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-2 at the preventive visit; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-PREV",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-17",
        "value": 182,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid screen at the preventive visit; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-PREV",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-17",
        "value": 64,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid screen at the preventive visit; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-PREV",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-17",
        "value": 101,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid screen at the preventive visit; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-PREV",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-17",
        "value": 85,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting lipid screen at the preventive visit; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEF-SICK",
        "display": "Maximum expiratory gas flow Respiratory system airway by Peak flow meter",
        "label": "Peak expiratory flow",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-08",
        "value": 300,
        "unit": "L/min",
        "reference_range": {
          "low": 352,
          "text": "80 percent of his personal best of 440 L/min"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19935-6",
            "display": "Maximum expiratory gas flow Respiratory system airway by Peak flow meter",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic clinic peak flow with a cold: 68 percent of personal best, the yellow zone of his action plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PEF-V4",
        "display": "Maximum expiratory gas flow Respiratory system airway by Peak flow meter",
        "label": "Peak expiratory flow",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-10-22",
        "value": 430,
        "unit": "L/min",
        "reference_range": {
          "low": 352,
          "text": "80 percent of his personal best of 440 L/min"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19935-6",
            "display": "Maximum expiratory gas flow Respiratory system airway by Peak flow meter",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic clinic peak flow two weeks after the cold, back to 98 percent of personal best.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ACT-V4",
        "display": "Total score [ACT]",
        "label": "Asthma Control Test",
        "status": "final",
        "effective_date": "2026-10-22",
        "value": 21,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82668-5",
            "display": "Total score [ACT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Asthma Control Test after recovery from the cold, now well controlled.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Chest X-ray, posteroanterior and lateral: mild hyperinflation; normal heart size; no consolidation, mass, cavitation, hilar enlargement, or effusion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-12",
          "end": "2026-03-12"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chest X-ray at presentation; no sign of tuberculosis, tumor, or heart failure.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "CT of the chest without contrast, with expiratory images: diffuse bronchial wall thickening and mosaic attenuation with air trapping on expiration; no emphysema, bronchiectasis, nodules, lymph node enlargement, or interstitial lung disease",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "169069000",
            "display": "CT of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-26",
          "end": "2026-03-26"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic CT for persistent airflow limitation in a never-smoker, done on the consultation day: findings of airway disease without emphysema.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2021-05-10",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Influenza vaccine, last season",
        "status": "completed",
        "date": "2025-10-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-03-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination at the diagnosis visit; recommended for all adults aged 50 and over and for adults with chronic lung disease.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-09-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T10:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "COVID-19 mRNA vaccine, this season's formula",
        "status": "completed",
        "date": "2026-09-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T10:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Respiratory syncytial virus vaccine, single dose",
        "status": "completed",
        "date": "2026-09-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "303",
            "display": "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic RSV vaccination: recommended at 60 to 74 for adults at increased risk, including chronic lung disease.",
          "author": "The Human Record generator",
          "created": "2026-11-06T10:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-10-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first zoster vaccine dose, deferred from the preventive visit at his request.",
          "author": "The Human Record generator",
          "created": "2026-11-06T11:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "condition": "Died at about 54 of consumption or some kindred malady, by his biographer's account",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "FH-002",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "BRO",
          "display": "brother",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "condition": "Died of consumption at about 26, by his biographer's account",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "A cough that began about the age of 38 and troubled him thereafter, by his biographer's account",
        "historical_date": {
          "iso": "1670",
          "display": "About 1670",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Unable to stay long in London because of its coal smoke, and away from the city every winter",
        "historical_date": {
          "iso": "1679",
          "display": "From 1679",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Moved to the country because the smoke of London harmed his health; wrote that his lungs could not bear the smoke of the city",
        "historical_date": {
          "iso": "1691",
          "display": "1691 to 1692",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Primary care visit for a lifelong cough with wheeze and breathlessness, worse in city air and by open fires, in a never-smoker",
        "status": "finished",
        "date": "2026-03-12",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review of lung function and blood tests, diagnosis, start of treatment, and pulmonology consultation",
        "status": "finished",
        "date": "2026-03-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Two-week review of lung function and blood tests; pulmonology consultation today",
          "hpi": {
            "narrative": "Mr. Locke returns two weeks after his first visit. He has used albuterol once or twice a day, and not since early this morning, six hours before his tests. The open fires in his rooms have not been lit since his first visit; the household has put electric heaters in his study and bedroom, and a HEPA air cleaner runs in each. He has stayed in the country and checks the air quality index each morning. His night cough has eased to two nights a week, but he is still breathless on stairs and hills and wheezes in the cold. He has had no fever, weight loss, night sweats, or blood in his sputum. This morning he had full lung function tests, a six-minute walk, and a CT of the chest, and saw Dr. Nwankwo-Fairfax of pulmonology.",
            "elements": [
              {
                "label": "Reliever use",
                "value": "Albuterol once or twice a day; withheld six hours before testing"
              },
              {
                "label": "Exposure",
                "value": "No open fires since intake; electric heating; HEPA air cleaners running; no city trips"
              },
              {
                "label": "Symptoms",
                "value": "Night cough two nights a week; breathless on stairs and hills"
              },
              {
                "label": "Asthma Control Test",
                "value": "13, up from 12"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats, or weight loss"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No nasal blockage, postnasal drip, or loss of smell"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Cough at night two nights a week, wheeze in cold air, breathless on exertion; no hemoptysis"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, ankle swelling, or breathlessness lying flat"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No heartburn or acid regurgitation"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, comfortable at rest"
            },
            {
              "system": "Respiratory",
              "finding": "Prolonged expiration with scattered expiratory wheeze; no crackles; no clubbing; oxygen saturation 95 percent"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; jugular venous pressure not raised; no edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Asthma with persistent airflow limitation, type 2 phenotype",
              "assessment": "Before bronchodilator, FEV1 2.11 L (62 percent predicted) and FEV1/FVC 0.57; after albuterol, FEV1 2.49 L, a rise of 380 mL (11 percent of predicted, a positive response by the ATS/ERS 2022 criterion), with FEV1/FVC 0.62, still below the lower limit of normal (0.67) and below 0.70: airflow limitation that is partly reversible but persists after bronchodilator. FeNO 41 ppb, blood eosinophils 0.46 x 10^3/uL, and IgE 186 IU/mL show type 2 airway inflammation; DLCO 26.4 is normal and the CT shows bronchial wall thickening and air trapping without emphysema or bronchiectasis. Alpha-1 antitrypsin is normal, the interferon-gamma release assay is negative, NT-proBNP is normal, and the chest X-ray is clear. COPD from non-tobacco exposures was considered, because GOLD recognizes COPD in never-smokers exposed to air pollution and solid-fuel smoke and his post-bronchodilator ratio is below 0.70. The features favor asthma: symptoms from his late thirties that vary with season, cold, and smoke, a large bronchodilator response, raised FeNO and eosinophils, no emphysema, and a normal DLCO. The persistent limitation is best explained by long-standing asthma, with pollution and indoor smoke as aggravating causes. Dr. Nwankwo-Fairfax agrees. Because GINA and GOLD advise that anyone with asthma features be treated as asthma, inhaled corticosteroid is essential and a long-acting bronchodilator alone is not safe",
              "plan": [
                "Budesonide-formoterol 160/4.5 mcg, two inhalations twice daily and one as needed, no more than 12 a day (GINA track 1, step 4), starting today",
                "Stop albuterol",
                "Inhaler technique taught with his own device and checked by teach-back",
                "Written asthma action plan given; home peak flow twice daily to find his personal best",
                "Pulmonary rehabilitation program, eight weeks, starting next week",
                "Pneumococcal conjugate vaccine PCV20 today",
                "Review in twelve weeks with repeat spirometry and FeNO"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Chronic cough with wheeze and breathlessness",
              "assessment": "Explained by asthma with persistent airflow limitation; superseded by that diagnosis. Tuberculosis, alpha-1 antitrypsin deficiency, heart failure, and a tumor are excluded",
              "plan": [
                "Managed under the asthma problem"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Exposure to air pollution and indoor solid-fuel smoke",
              "assessment": "Removing the open fires is the largest change within his control. Fine particles from coal, wood, and traffic aggravate asthma and add to airflow limitation; the WHO 2021 guideline values for PM2.5 are 5 ug/m3 as an annual mean and 15 ug/m3 over 24 hours",
              "plan": [
                "Keep the open fires out of use; HEPA air cleaners in his study and bedroom",
                "Check the air quality index each morning; on days of 101 or more (unhealthy for sensitive groups) avoid outdoor exertion and postpone city trips",
                "A well-fitted N95 respirator for unavoidable time outdoors on alert days; walk away from main roads"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Asthma Control Test",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "13, up from 12; still very poorly controlled",
              "observation_ids": [
                "OBS-ACT-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Spirometry before and after bronchodilator (FEV1, FVC, FEV1/FVC, bronchodilator response)",
              "cadence": "At diagnosis, 3 to 6 months after starting treatment, then every 1 to 2 years",
              "status": "completed_today",
              "detail": "FEV1 2.11 L before (62 percent predicted) and 2.49 L after albuterol (+380 mL); FVC 3.71 L before and 4.02 L after; FEV1/FVC 0.57 before and 0.62 after, below the lower limit of normal; GLI Global race-neutral equations",
              "observation_ids": [
                "OBS-FEV1PRE-V2",
                "OBS-FVCPRE-V2",
                "OBS-RATIOPRE-V2",
                "OBS-FEV1PCT-V2",
                "OBS-FEV1POST-V2",
                "OBS-FVCPOST-V2",
                "OBS-RATIOPOST-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-ATS-ERS-PFT-2022",
                "GL-ATS-RACE-2023",
                "GL-CMID-2026",
                "GL-GOLD-2025"
              ]
            },
            {
              "domain": "imaging",
              "measure": "FeNO",
              "cadence": "When the diagnosis is uncertain, and to monitor inhaled-corticosteroid response",
              "status": "completed_today",
              "detail": "41 ppb, intermediate, before any inhaled corticosteroid",
              "observation_ids": [
                "OBS-FENO-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Diffusing capacity (DLCO)",
              "cadence": "Once, for persistent airflow limitation",
              "status": "completed_today",
              "detail": "26.4 mL/min/mmHg, normal",
              "observation_ids": [
                "OBS-DLCO-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GOLD-2025",
                "GL-ATS-ERS-PFT-2022",
                "GL-ATS-RACE-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Six-minute walk test",
              "cadence": "Before and after pulmonary rehabilitation",
              "status": "completed_today",
              "detail": "430 m, below the lower limit of about 480 m; lowest saturation 94 percent",
              "observation_ids": [
                "OBS-SMWT-V2"
              ],
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-ATS-PR-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood eosinophils and total IgE",
              "cadence": "At diagnosis and at any severe-asthma workup",
              "status": "completed_today",
              "detail": "Results from the first visit reviewed today: eosinophils 0.46 x 10^3/uL; IgE 186 IU/mL",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Alpha-1 antitrypsin level",
              "cadence": "Once, for persistent airflow limitation",
              "status": "completed_today",
              "detail": "Result from the first visit reviewed today: 131 mg/dL, normal",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GOLD-2025"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest imaging (X-ray; CT)",
              "cadence": "Chest X-ray or CT only for atypical features or a suspected complication",
              "status": "completed_today",
              "detail": "Chest X-ray at the first visit clear; CT today for persistent airflow limitation in a never-smoker: airway wall thickening and air trapping, no emphysema, bronchiectasis, or nodules",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-CMID-2026",
                "GL-GOLD-2025"
              ]
            },
            {
              "domain": "examination",
              "measure": "Inhaler technique with his own devices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Taught today with his new budesonide-formoterol inhaler; correct by teach-back",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and reliever use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Albuterol once or twice a day until today, when it is stopped and replaced by budesonide-formoterol as needed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Exacerbation history (oral corticosteroid courses, emergency visits, admissions in the past 12 months)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Trigger and exposure review: indoor solid-fuel smoke, outdoor air pollution and air quality alerts, tobacco and vaping, occupational exposures, allergens",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Open fires out of use since intake; electric heating; HEPA air cleaners in his study and bedroom; air quality index checked each morning; no city trips since intake",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-WHO-AQG-2021",
                "GL-ERS-AIR-2020",
                "GL-AIRNOW-AQI",
                "GL-EPA-AIRCLEAN"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Smoking and vaping status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never smoker; no vaping; no secondhand smoke",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Written asthma action plan",
              "cadence": "Every visit and after every flare",
              "status": "completed_today",
              "detail": "First written plan given today, symptom-based; peak-flow zones to be added once his personal best is known",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Step-up and step-down assessment",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Started at GINA track 1, step 4 (medium-dose budesonide-formoterol maintenance and reliever) for very poorly controlled asthma with low lung function",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Comorbidity surveillance: rhinitis and sinus disease, reflux, obesity, sleep apnea, vocal cord dysfunction, anxiety and depression",
              "cadence": "At diagnosis and at least yearly",
              "status": "up_to_date",
              "detail": "Screened at the first visit: no rhinitis, reflux, or snoring; BMI 19.6; PHQ-2 1",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Pulmonary rehabilitation",
              "cadence": "For persistent breathlessness or reduced exercise capacity",
              "status": "ordered",
              "detail": "Eight-week program starting next week",
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-CMID-2026",
                "GL-ATS-PR-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Pulmonology consultation",
              "cadence": "For diagnostic uncertainty or persistent airflow limitation",
              "status": "completed_today",
              "detail": "Seen today; agrees with asthma with persistent airflow limitation and the plan",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-CMID-2026",
                "GL-GOLD-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccination status",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "PCV20 today; influenza, COVID-19, and RSV vaccines due in the autumn; Tdap up to date",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Biologic candidacy",
              "cadence": "When asthma is severe and uncontrolled despite optimized step 4 to 5 treatment with confirmed adherence and technique",
              "status": "not_indicated",
              "detail": "No exacerbations needing oral corticosteroids and not uncontrolled on optimized treatment",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            }
          ],
          "follow_up": "Asthma review in twelve weeks with repeat spirometry and FeNO; call sooner if the reliever is needed more than usual",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-GINA-2025",
            "GL-NAEPP-2020",
            "GL-GOLD-2025",
            "GL-ATS-ERS-PFT-2022",
            "GL-ATS-RACE-2023",
            "GL-ATS-PR-2023",
            "GL-WHO-AQG-2021",
            "GL-ERS-AIR-2020",
            "GL-AIRNOW-AQI",
            "GL-EPA-AIRCLEAN",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Twelve-week asthma review with repeat spirometry after pulmonary rehabilitation",
        "status": "finished",
        "date": "2026-06-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Twelve-week asthma review with repeat spirometry",
          "hpi": {
            "narrative": "Mr. Locke returns twelve weeks after starting budesonide-formoterol as maintenance and reliever. He finished the eight-week pulmonary rehabilitation program, attending all 16 sessions, and walks 30 minutes five days a week. He needs three or four extra inhalations a week, mostly after his days in the city, and woke at night with cough once in the past month. He has had no flare and no oral corticosteroids. The dose counter matches his diary, with about one missed evening dose a fortnight. He has had no hoarseness or sore mouth. His home peak flow is best at 440 L/min in the mornings and falls to about 360 after a city day. The open fires stay out; a small air monitor in his study usually reads below 10 ug/m3 of PM2.5. He has spent two or three days a month in the city and stayed away during an air quality alert in May.",
            "elements": [
              {
                "label": "Reliever use",
                "value": "Three or four extra inhalations a week"
              },
              {
                "label": "Night waking",
                "value": "Once in the past month"
              },
              {
                "label": "Adherence",
                "value": "About one missed maintenance dose a fortnight; dose counter agrees"
              },
              {
                "label": "Rehabilitation",
                "value": "16 of 16 sessions completed"
              },
              {
                "label": "Peak flow",
                "value": "Personal best 440 L/min"
              },
              {
                "label": "Asthma Control Test",
                "value": "19, up from 13"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Breathless on steep hills; some cough and tightness after city days; no hemoptysis"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hoarseness, sore mouth, or thrush"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations, tremor, or ankle swelling"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 62.8 kg"
            },
            {
              "system": "Mouth",
              "finding": "No oral candidiasis"
            },
            {
              "system": "Respiratory",
              "finding": "Good air entry; a few end-expiratory wheezes on forced expiration; oxygen saturation 97 percent"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Asthma with persistent airflow limitation, type 2 phenotype",
              "assessment": "Much better but not yet well controlled: Asthma Control Test 19 and reliever use three or four times a week, with no flares. FEV1 2.46 L before bronchodilator (73 percent predicted), up 350 mL, and 2.58 L after, with a post-bronchodilator FEV1/FVC of 0.63, still below the lower limit of normal: a large improvement, but airflow limitation persists. FeNO has fallen from 41 to 22 ppb, showing that he is taking the inhaled corticosteroid and that his type 2 inflammation has responded. Adherence and technique are good. The six-minute walk improved by 75 m after rehabilitation. Because residual symptoms come with persistent airflow limitation and low FeNO, adding tiotropium (GINA step 5 add-on LAMA) is preferred over a higher corticosteroid dose; a biologic is not indicated",
              "plan": [
                "Add tiotropium 2.5 mcg soft-mist inhaler, two inhalations once daily; technique taught today",
                "Continue budesonide-formoterol two inhalations twice daily plus one as needed, no more than 12 a day",
                "Action plan updated with peak-flow zones from his best of 440 L/min: green 352 or more, yellow 220 to 351, red below 220",
                "Keep up the walking program",
                "Review at his preventive visit in three months and with an Asthma Control Test at four months"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Exposure to air pollution and indoor solid-fuel smoke",
              "assessment": "Indoor smoke removed; outdoor exposure reduced by planning around alerts. City days still bring symptoms",
              "plan": [
                "Continue the exposure plan; keep city visits to days with an air quality index below 100"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Asthma Control Test",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "19, up from 13; not yet well controlled (20 or more)",
              "observation_ids": [
                "OBS-ACT-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Spirometry before and after bronchodilator",
              "cadence": "At diagnosis, 3 to 6 months after starting treatment, then every 1 to 2 years",
              "status": "completed_today",
              "detail": "FEV1 2.46 L before (73 percent predicted) and 2.58 L after bronchodilator; FVC 4.12 L after; FEV1/FVC 0.63 after, still below the lower limit of normal; next in one to two years",
              "observation_ids": [
                "OBS-FEV1PRE-V3",
                "OBS-FEV1PCT-V3",
                "OBS-FEV1POST-V3",
                "OBS-FVCPOST-V3",
                "OBS-RATIOPOST-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-ATS-ERS-PFT-2022",
                "GL-ATS-RACE-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "FeNO",
              "cadence": "To monitor inhaled-corticosteroid response",
              "status": "completed_today",
              "detail": "22 ppb, down from 41",
              "observation_ids": [
                "OBS-FENO-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Six-minute walk test",
              "cadence": "Before and after pulmonary rehabilitation",
              "status": "completed_today",
              "detail": "505 m, up 75 m from 430 m",
              "observation_ids": [
                "OBS-SMWT-V3"
              ],
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-ATS-PR-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Home peak expiratory flow",
              "cadence": "Daily for moderate to severe asthma, then with symptoms",
              "status": "completed_today",
              "detail": "Diary reviewed: personal best 440 L/min; about 360 after city days",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Inhaler technique with his own devices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Budesonide-formoterol technique correct; tiotropium soft-mist inhaler taught today, correct by teach-back",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and reliever use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "About one missed maintenance dose a fortnight by dose counter and diary; three or four as-needed inhalations a week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Inhaled-corticosteroid side effects (hoarseness, thrush)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Exacerbation history",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None since treatment began; no oral corticosteroids",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Trigger and exposure review: indoor solid-fuel smoke, outdoor air pollution and air quality alerts, tobacco and vaping, occupational exposures, allergens",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Open fires out of use; indoor PM2.5 on his monitor usually below 10 ug/m3; HEPA air cleaners running; city trip postponed during an air quality alert",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-WHO-AQG-2021",
                "GL-ERS-AIR-2020",
                "GL-AIRNOW-AQI",
                "GL-EPA-AIRCLEAN"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Smoking and vaping status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never smoker; no vaping; no secondhand smoke",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Written asthma action plan",
              "cadence": "Every visit and after every flare",
              "status": "completed_today",
              "detail": "Updated with peak-flow zones: green 352 or more, yellow 220 to 351, red below 220 L/min",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Step-up and step-down assessment",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Not well controlled on step 4 with good adherence and technique: step up by adding tiotropium (step 5)",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Pulmonary rehabilitation",
              "cadence": "For persistent breathlessness or reduced exercise capacity",
              "status": "completed_today",
              "detail": "Program completed; home walking program to maintain the gain",
              "guideline_ids": [
                "GL-GINA-2025",
                "GL-ATS-PR-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccination status",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "PCV20 given at the diagnosis visit; influenza, COVID-19, and RSV vaccines due in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Biologic candidacy",
              "cadence": "When asthma is severe and uncontrolled despite optimized step 4 to 5 treatment with confirmed adherence and technique",
              "status": "not_indicated",
              "detail": "No exacerbations needing oral corticosteroids and not uncontrolled on optimized treatment",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            }
          ],
          "follow_up": "Preventive visit in three months, with a brief asthma check; asthma review with an Asthma Control Test in four months",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-GINA-2025",
            "GL-NAEPP-2020",
            "GL-ATS-ERS-PFT-2022",
            "GL-ATS-RACE-2023",
            "GL-ATS-PR-2023",
            "GL-WHO-AQG-2021",
            "GL-ERS-AIR-2020",
            "GL-AIRNOW-AQI",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Asthma review two weeks after a cold with a yellow-zone flare",
        "status": "finished",
        "date": "2026-10-22",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Asthma review two weeks after a cold with a yellow-zone flare",
          "hpi": {
            "narrative": "Mr. Locke returns two weeks after his sick visit for a cold that triggered a yellow-zone flare. He took up to 11 inhalations of budesonide-formoterol on the worst day and never needed prednisolone. His peak flow climbed back above 400 L/min by the fifth day and has been 420 to 440 since. The cold cleared in about a week, and he stopped acetaminophen after four days. The review planned for one week after the sick visit did not take place: the clinic's first slot was today. He now needs his reliever about once a week, sleeps through the night, and has no side effects from tiotropium (no dry mouth, difficulty passing urine, or eye pain). The open fires remain out of use. He would like his first zoster vaccine today.",
            "elements": [
              {
                "label": "Flare",
                "value": "Yellow zone with a cold; managed by the action plan without prednisolone"
              },
              {
                "label": "Peak flow",
                "value": "Back to 420 to 440 L/min; 430 in clinic today"
              },
              {
                "label": "Reliever use",
                "value": "About once a week"
              },
              {
                "label": "Tiotropium",
                "value": "Four months; no side effects"
              },
              {
                "label": "Asthma Control Test",
                "value": "21"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; energy back to normal"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, wheeze, or night waking now; breathless only on steep hills"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No difficulty passing urine"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No eye pain or blurred vision"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well"
            },
            {
              "system": "Respiratory",
              "finding": "Clear on quiet and forced breathing; oxygen saturation 97 percent"
            },
            {
              "system": "Mouth",
              "finding": "No candidiasis"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Asthma with persistent airflow limitation, type 2 phenotype",
              "assessment": "Well controlled (Asthma Control Test 21; reliever about once a week; no night symptoms) on budesonide-formoterol with tiotropium. One yellow-zone flare with a cold, managed correctly by his action plan without oral corticosteroids. Too soon after a flare, and with persistent airflow limitation, to step down; reconsider after three months of good control",
              "plan": [
                "Continue budesonide-formoterol two inhalations twice daily plus as needed and tiotropium two inhalations daily",
                "Action plan reviewed; unchanged",
                "After any future flare, the clinic books a review within one week",
                "Recombinant zoster vaccine dose 1 today; dose 2 in two to six months",
                "Asthma review in three months; spirometry within a year of the last"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Acute viral upper respiratory infection with a yellow-zone flare",
              "assessment": "Resolved",
              "plan": [
                "No further action"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Exposure to air pollution and indoor solid-fuel smoke",
              "assessment": "Exposure plan maintained; heating season starting",
              "plan": [
                "Keep the open fires out of use through the winter; replace the HEPA filters as the maker advises"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Asthma Control Test",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "21: well controlled",
              "observation_ids": [
                "OBS-ACT-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Peak expiratory flow",
              "cadence": "At each visit after a flare, and at home with symptoms",
              "status": "completed_today",
              "detail": "430 L/min in clinic, 98 percent of his best",
              "observation_ids": [
                "OBS-PEF-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Review within one week after a flare",
              "cadence": "Within one week of any exacerbation",
              "status": "deferred",
              "detail": "Missed: the one-week review planned at the sick visit was not booked because no slot was free, and no telephone check was arranged. No harm resulted: his diary shows the peak flow back above 400 L/min by the fifth day without prednisolone. Corrective action: the clinic now books a review within one week, by telephone if no slot is free, whenever he calls or is seen for a flare, and this is written into his care plan",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Review 1 to 3 months after a controller change, with an Asthma Control Test",
              "cadence": "1 to 3 months after starting or changing controller treatment",
              "status": "deferred",
              "detail": "Partly missed: the twelve-week plan set the full review with an Asthma Control Test at four months, beyond the protocol's 1 to 3 months. The preventive visit at 13 weeks reviewed his symptoms, reliever use, and side effects, but no Asthma Control Test was recorded until today. No harm: he was well controlled at that visit and today. Corrective action: an Asthma Control Test is recorded at any visit where asthma is reviewed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Inhaler technique with his own devices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Both inhalers used correctly",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and reliever use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No missed doses since the flare; reliever about once a week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Tiotropium side effects (dry mouth, urinary retention, angle-closure glaucoma symptoms)",
              "cadence": "After starting and at each visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Exacerbation history",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "One yellow-zone flare with a cold; no oral corticosteroids, emergency visits, or admissions",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Trigger and exposure review: indoor solid-fuel smoke, outdoor air pollution and air quality alerts, tobacco and vaping, occupational exposures, allergens",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Open fires out of use; HEPA air cleaners running; air quality index checked before city trips; no new exposures",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-WHO-AQG-2021",
                "GL-ERS-AIR-2020",
                "GL-AIRNOW-AQI",
                "GL-EPA-AIRCLEAN"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Smoking and vaping status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never smoker; no vaping; no secondhand smoke",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Written asthma action plan",
              "cadence": "Every visit and after every flare",
              "status": "completed_today",
              "detail": "Reviewed after the flare; he used it correctly; unchanged",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Step-up and step-down assessment",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Well controlled at step 5 (add-on tiotropium); no step-down so soon after a flare; reconsider after three months of good control",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Spirometry",
              "cadence": "Every 1 to 2 years once stable",
              "status": "up_to_date",
              "detail": "Last done four months ago; next within a year",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020",
                "GL-ATS-ERS-PFT-2022",
                "GL-ATS-RACE-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "FeNO",
              "cadence": "To monitor inhaled-corticosteroid response when needed",
              "status": "not_indicated",
              "detail": "Low on treatment four months ago; control is good",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Comorbidity surveillance",
              "cadence": "At diagnosis and at least yearly",
              "status": "up_to_date",
              "detail": "Screened at diagnosis; PHQ-2 0 at the preventive visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccination status",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "Influenza, COVID-19, and RSV vaccines given five weeks ago; zoster dose 1 today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Biologic candidacy",
              "cadence": "When asthma is severe and uncontrolled despite optimized step 4 to 5 treatment with confirmed adherence and technique",
              "status": "not_indicated",
              "detail": "No exacerbations needing oral corticosteroids and not uncontrolled on optimized treatment",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-GINA-2025",
                "GL-NAEPP-2020"
              ]
            }
          ],
          "follow_up": "Asthma review in three months; zoster dose 2 in two to six months; spirometry within a year of the last",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-GINA-2025",
            "GL-NAEPP-2020",
            "GL-ATS-ERS-PFT-2022",
            "GL-WHO-AQG-2021",
            "GL-ERS-AIR-2020",
            "GL-AIRNOW-AQI",
            "GL-EPA-AIRCLEAN",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Preventive health visit at 60",
        "status": "finished",
        "date": "2026-09-17",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Preventive health visit at 60",
          "billing_note": "Periodic preventive medicine visit, established patient, age 40 to 64, with voluntary advance care planning",
          "hpi": {
            "narrative": "Mr. Locke returns for his preventive visit, having turned 60 last week. He completed the health risk questionnaire beforehand. His asthma has been steady in the three months since tiotropium was added: he uses one or two extra inhalations of budesonide-formoterol a week, sleeps through the night, and has had no flare. The dose counters show no missed maintenance doses. He finished pulmonary rehabilitation in the spring and keeps up the walking program five days a week. The open fires in his rooms have stayed out of use, and the HEPA air cleaner runs in his study and bedroom. He spent four days in the city last month, checked the air quality index each morning, and needed his reliever twice. He has had no fever, weight loss, night sweats, or blood in his sputum. He had a normal colonoscopy eight years ago.",
            "elements": [
              {
                "label": "Visit",
                "value": "Preventive health visit, age 60"
              },
              {
                "label": "Active conditions",
                "value": "Asthma with persistent airflow limitation on budesonide-formoterol maintenance and reliever with add-on tiotropium; exposure to air pollution"
              },
              {
                "label": "Medicines",
                "value": "Budesonide-formoterol 160/4.5 mcg two inhalations twice daily plus as needed; tiotropium 2.5 mcg two inhalations daily"
              },
              {
                "label": "Screening history",
                "value": "Normal colonoscopy eight years ago; HIV, hepatitis B, and hepatitis C tests negative in his fifties"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, better than for many years"
            },
            {
              "domain": "Psychosocial",
              "finding": "Lives with long-standing friends; busy with writing and his board work; no financial worries"
            },
            {
              "domain": "Behavioral",
              "finding": "Never smoker; wine a few evenings a week (AUDIT-C 2); walks 30 to 40 minutes five days a week; plain diet with fruit and vegetables most days"
            },
            {
              "domain": "Environmental",
              "finding": "No open fires in his rooms; HEPA air cleaner in study and bedroom; checks the air quality index before city trips"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke and carbon monoxide alarms fitted; no firearms"
            },
            {
              "domain": "Sexual health",
              "finding": "Not sexually active; no risk factors for sexually transmitted infection"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No hearing difficulty; reading glasses; eye examination last year"
            },
            {
              "domain": "Sleep",
              "finding": "Sleeps through the night; no snoring reported"
            },
            {
              "domain": "Pain",
              "finding": "None"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight 63.0 kg, up 1 kg since spring; no fever or night sweats"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hoarseness, sore mouth, or thrush on inhaled corticosteroid; no nasal blockage"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, ankle swelling, or breathlessness lying flat"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Mild breathlessness on hills; occasional cough after city days; no wheeze at rest; no hemoptysis"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No heartburn, bleeding, or change in bowel habit"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary hesitancy or retention on tiotropium; no nocturia"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or easy bruising"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, numbness, or weakness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Thin, well; BMI 19.9"
            },
            {
              "system": "Mouth",
              "finding": "No oral candidiasis"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no edema; blood pressure 120/74 mmHg"
            },
            {
              "system": "Respiratory",
              "finding": "Good air entry; faint end-expiratory wheeze on forced expiration only; oxygen saturation 97 percent"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no masses"
            },
            {
              "system": "Skin",
              "finding": "No bruising or thinning"
            }
          ],
          "assessment_plan": [
            {
              "display": "Preventive health visit completed",
              "assessment": "Health risk assessment reviewed and a personalized prevention plan made. His chief risk is his chronic airway disease, now well managed, which makes the seasonal respiratory vaccines a priority. Lipids are normal and his estimated 10-year cardiovascular risk is below 7.5 percent",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Asthma with persistent airflow limitation",
              "assessment": "Steady three months after adding tiotropium: reliever once or twice a week, no night symptoms, no flare; no inhaled-corticosteroid side effects",
              "plan": [
                "Continue budesonide-formoterol and tiotropium",
                "Asthma review with an Asthma Control Test as booked next month",
                "Influenza, COVID-19, and RSV vaccines today"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine, this season",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "RSV vaccine",
              "status": "completed_today",
              "detail": "Single dose given today; recommended at 60 to 74 with chronic lung disease",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "due",
              "detail": "Recommended from 50; he preferred not to have a fourth injection today and will have dose 1 at his next visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal conjugate vaccine",
              "status": "up_to_date",
              "detail": "PCV20 given six months ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus booster",
              "status": "up_to_date",
              "detail": "Tdap five years ago"
            },
            {
              "service": "Colorectal cancer screening",
              "status": "up_to_date",
              "detail": "Normal colonoscopy eight years ago; next due in two years",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Lipid screening and cardiovascular risk",
              "status": "completed_today",
              "detail": "Total cholesterol 182 mg/dL, HDL 64 mg/dL, LDL 101 mg/dL, triglycerides 85 mg/dL; blood pressure 120/74 mmHg; never smoker; no diabetes; estimated 10-year risk below 7.5 percent, so no statin",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "not_indicated",
              "detail": "BMI 19.9 with no other risk factors"
            },
            {
              "service": "HIV, hepatitis B, and hepatitis C screening",
              "status": "up_to_date",
              "detail": "One-time tests negative in his fifties"
            },
            {
              "service": "Alcohol misuse screening",
              "status": "completed_today",
              "detail": "AUDIT-C 2"
            },
            {
              "service": "Prostate cancer screening",
              "status": "declined",
              "detail": "Shared decision about PSA screening at 55 to 69 discussed; he chose not to be screened this year",
              "guideline_ids": [
                "GL-USPSTF-PSA-2018"
              ]
            },
            {
              "service": "Lung cancer and abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Never smoker; CT this spring showed no nodules",
              "guideline_ids": [
                "GL-USPSTF-LUNG-2021"
              ]
            },
            {
              "service": "Hearing and vision",
              "status": "up_to_date",
              "detail": "No concerns; eye examination last year"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 17 minutes, with his consent. He has not written a directive before. He names a long-standing friend in the household where he lives as his health care agent and took the state form to complete. He would want full treatment for any illness he might recover from, including a period on a ventilator for a severe asthma attack, and would not want his life prolonged by machines if he could not recover awareness. He asked that his health information be shared with his care team and his agent.",
          "follow_up": "Asthma review next month as booked; zoster vaccine dose 1 then",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-DEP-2023",
            "GL-USPSTF-STATIN-2022",
            "GL-USPSTF-PSA-2018",
            "GL-USPSTF-LUNG-2021",
            "GL-GINA-2025"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T10:00:00-05:00"
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for a cold with a yellow-zone asthma flare",
        "status": "finished",
        "date": "2026-10-08",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "A cold for three days, now with cough, wheeze, and a lower peak flow",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Locke is a 60-year-old man with asthma and persistent airflow limitation on budesonide-formoterol maintenance and reliever therapy with tiotropium, who called this morning and was seen the same day. Three days ago he developed a sore throat and runny nose after a houseguest's cold; since yesterday he has had a cough, wheeze, and tightness, and woke twice last night. His home peak flow has been 290 to 310 L/min against a personal best of 440, the yellow zone of his action plan. Following the plan, he has taken five or six extra inhalations of budesonide-formoterol a day on top of his four maintenance inhalations, never more than 12 in a day, with relief for several hours each time. He has had a temperature of 37.6 C, no shaking chills, no chest pain, and no colored sputum. A home COVID-19 test yesterday was negative. He had this season's influenza, COVID-19, and RSV vaccines three weeks ago.",
            "elements": [
              {
                "label": "Onset",
                "value": "Cold three days ago; chest symptoms since yesterday"
              },
              {
                "label": "Severity",
                "value": "Home peak flow 290 to 310 L/min (66 to 70 percent of best); woke twice last night"
              },
              {
                "label": "Treatment so far",
                "value": "Five or six extra budesonide-formoterol inhalations a day, within 12 a day; tiotropium continued"
              },
              {
                "label": "Pertinent negatives",
                "value": "No high fever, chest pain, colored sputum, or breathlessness at rest; home COVID-19 test negative"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Low-grade temperature and tiredness; eating and drinking normally"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Sore throat and clear runny nose; no ear or facial pain"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Cough, wheeze, and chest tightness; no hemoptysis or pleuritic pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, or ankle swelling"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but comfortable; speaks in full sentences; no use of accessory muscles"
            },
            {
              "system": "Ears, nose, and throat",
              "finding": "Clear nasal discharge; mild pharyngeal redness without exudate"
            },
            {
              "system": "Respiratory",
              "finding": "Scattered expiratory wheeze throughout both lungs; no crackles or bronchial breathing; respiratory rate 20; oxygen saturation 95 percent"
            },
            {
              "system": "Cardiovascular",
              "finding": "Heart rate 94, regular; no edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Acute viral upper respiratory infection with a yellow-zone asthma flare",
              "assessment": "A cold that has triggered a mild flare: clinic peak flow 300 L/min (68 percent of his best), wheeze without signs of a severe attack, oxygen saturation 95 percent, and a good response to extra as-needed budesonide-formoterol. No sign of pneumonia, so no chest X-ray and no antibiotic, following ACP and CDC advice. He has followed his action plan correctly",
              "plan": [
                "Continue maintenance inhalations and take extra budesonide-formoterol as needed, no more than 12 inhalations in a day",
                "Continue tiotropium",
                "Start prednisolone 40 mg daily for 5 days only if the peak flow falls below 264 L/min (60 percent of best), if he needs more than 12 inhalations a day, or if he is no better in 2 to 3 days; he will call the clinic first",
                "Red zone (peak flow below 220 L/min, breathless at rest, or not helped by his inhaler): call 911",
                "Acetaminophen for aches; honey and warm drinks for the cough; keep away from fires and smoky rooms",
                "Asthma review in one week"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Asthma with persistent airflow limitation",
              "assessment": "Well controlled before this cold; the flare is the first since treatment began",
              "plan": [
                "Action plan reviewed with him; peak flow twice daily until back to his best"
              ]
            }
          ],
          "follow_up": "Asthma review in one week; sooner for the warning signs above",
          "guideline_ids": [
            "GL-ACP-ARTI-2016",
            "GL-GINA-2025",
            "GL-CMID-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T10:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-12",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.1,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-06-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-09-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-08",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 94,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 20,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit, with a low-grade temperature.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-10-22",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measured height, weight, or blood pressure from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Occupation: philosopher and author; trained as a physician (bachelor of medicine) and still gives occasional informal medical advice; serves part-time on a government appeals board, which takes him into the city for a few days at a time",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern occupation echoing his documented medical training and public posts.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Home: for a year has lodged with long-standing friends in an old country house about 25 miles from the city; his study and bedroom are heated by open fires that burn coal and wood, and he reads by the fire most evenings; no gas cooking in his rooms; no damp or mould; no pets or birds",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic living situation; names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Exposure history: about 30 years living and working in a large city with heavy traffic and winter coal and wood smoke, in flats near main roads; breathless within a day of each return; no occupational dust, fume, or chemical exposure",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic exposure history echoing his documented intolerance of London's coal smoke; no historical level of exposure is asserted.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoker; never vaped; no secondhand tobacco smoke at home; a glass of wine with dinner a few times a week (AUDIT-C 2); no other substances",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance-use history.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Never married; no children; close to the household he lives with; walks most days in good weather",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic family and activity history; names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities of daily living; walks about a mile on the level at his own pace, but stops on hills and after one flight of stairs this winter; cannot stay in the city more than a day or two without severe breathlessness",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic functional impact.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, articulate, and good-humored; mood \"tired of being driven out of town\"; thought process orderly; no anxiety or low mood beyond frustration (PHQ-2 1)",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "A 59-year-old never-smoker with a cough since his late thirties and wheeze and breathlessness, worse every winter, in city air, and by open coal and wood fires at home. Please confirm the diagnosis (asthma, COPD from non-tobacco exposures, or both), advise on CT, and recommend treatment and pulmonary rehabilitation",
        "urgency": "Routine, within two to three weeks; he is not in distress and has a reliever",
        "pertinent_history": "Mr. Locke is a 59-year-old philosopher and author, trained in medicine, who has never smoked. He has coughed since his late thirties, worse each winter and within a day of any stay in the city, and better in warm weather and country air. For a year he has lodged in a country house where he reads most evenings by an open fire of coal and wood; before that he lived about 30 years in a large city near main roads. This winter he has had night cough two or three times a week, wheeze, and breathlessness after one flight of stairs, and after a recent city trip he could hardly breathe. No hemoptysis, fever, night sweats, weight loss, orthopnea, ankle swelling, reflux, or rhinitis. His father and brother died of consumption, by family account. Asthma Control Test 12; weight 62.0 kg, height 178 cm; oxygen saturation 95 percent; prolonged expiration with scattered wheeze; no clubbing or crackles. Chest X-ray today shows mild hyperinflation only. I have started albuterol as needed, asked him to stop using the open fires, and ordered a blood count with eosinophils, IgE, alpha-1 antitrypsin, NT-proBNP, and an interferon-gamma release assay. Full lung function tests with bronchodilator response, FeNO, and DLCO are booked at your laboratory on the day of your visit",
        "questions": [
          "Does he have asthma, COPD from non-tobacco exposures, or features of both, and how should the airflow limitation be interpreted?",
          "Is a CT of the chest indicated, and what does it show?",
          "What treatment do you recommend?",
          "Should he have pulmonary rehabilitation?",
          "How much do outdoor air pollution and indoor solid-fuel smoke contribute, and what exposure reduction do you advise?",
          "What monitoring and follow-up do you advise?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Locke is seen at the request of Dr. Hartwell-Osei. He has had a cough since his late thirties, with wheeze and breathlessness that have grown over the years; symptoms are worst in winter, in cold air, in the city, and by smoky fires, and ease in summer and in the country. He has never smoked or vaped and has had no occupational dust or fume exposure. He lived about 30 years in a large city near main roads and for the past year has lodged in a country house with open coal and wood fires, which have been out of use for two weeks. He has had no hemoptysis, fevers, night sweats, weight loss, nasal symptoms, reflux, or breathlessness lying flat. He has never had an oral corticosteroid course or an emergency visit for breathing. On albuterol as needed he uses one or two doses a day. His father and brother died of consumption",
        "data_reviewed": "Spirometry this morning (GLI Global race-neutral equations): FEV1 2.11 L (62 percent predicted) and FVC 3.71 L before bronchodilator, FEV1/FVC 0.57; 15 minutes after albuterol 400 mcg, FEV1 2.49 L (+380 mL, 11 percent of predicted) and FVC 4.02 L, FEV1/FVC 0.62 (lower limit of normal 0.67); DLCO 26.4 mL/min/mmHg (predicted 26.9); FeNO 41 ppb; six-minute walk 430 m with lowest saturation 94 percent. CT of the chest today without contrast, with expiratory images: diffuse bronchial wall thickening and mosaic attenuation with air trapping; no emphysema, bronchiectasis, nodules, or interstitial disease. From the first visit: eosinophils 0.46 x 10^3/uL, IgE 186 IU/mL, alpha-1 antitrypsin 131 mg/dL, NT-proBNP 58 pg/mL, interferon-gamma release assay negative (0.02 IU/mL), and a chest X-ray with mild hyperinflation only. Asthma Control Test 13 today",
        "exam": [
          {
            "system": "General",
            "finding": "Thin, comfortable at rest, speaking in full sentences"
          },
          {
            "system": "Respiratory",
            "finding": "Prolonged expiration with scattered expiratory wheeze; no crackles; no clubbing; oxygen saturation 95 percent"
          },
          {
            "system": "Cardiovascular",
            "finding": "Regular rhythm; jugular venous pressure not raised; no edema"
          },
          {
            "system": "Ears, nose, and throat",
            "finding": "Nasal mucosa normal; no polyps"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-003",
            "display": "Asthma with persistent airflow limitation, type 2 phenotype",
            "assessment": "He has airflow limitation that persists after bronchodilator (FEV1/FVC 0.62, below the lower limit of normal and below 0.70) with a large bronchodilator response. GOLD recognizes COPD in never-smokers from air pollution and solid-fuel smoke, so COPD was considered. The weight of evidence is for asthma: onset in his late thirties, symptoms that vary with season, cold, and smoke, a bronchodilator response of 380 mL, FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, a raised IgE, a normal DLCO, and a CT showing airway disease without emphysema. The persistent limitation most likely reflects decades of under-treated asthma with airway remodeling, worsened by pollution and indoor smoke. Treat as asthma: an inhaled corticosteroid is essential, and a long-acting bronchodilator without one is unsafe. Tuberculosis, alpha-1 antitrypsin deficiency, heart failure, and bronchiectasis are excluded"
          },
          {
            "problem_id": "PRB-002",
            "display": "Exposure to air pollution and indoor solid-fuel smoke",
            "assessment": "Fine particles from coal, wood, and traffic smoke are well-established triggers of asthma symptoms and flares and contribute to lower lung function. Removing indoor solid-fuel smoke is the most effective step within his control; outdoor exposure can be reduced but not removed"
          }
        ],
        "recommendations": [
          "Diagnosis: asthma with persistent airflow limitation, type 2 phenotype; not COPD. Record the reasoning, and repeat spirometry after three months of treatment to find his best lung function",
          "CT was indicated for persistent airflow limitation in a never-smoker and was done today; it shows airway disease without emphysema or bronchiectasis. No further imaging unless new features appear",
          "Start budesonide-formoterol 160/4.5 mcg, two inhalations twice daily and one as needed, no more than 12 a day (GINA track 1, step 4), and stop albuterol. Teach technique with his own device and give a written action plan. If he is not well controlled at three months despite good adherence and technique, add tiotropium 2.5 mcg two inhalations daily; consider a biologic only if he has flares needing oral corticosteroids despite that",
          "Yes: an eight-week pulmonary rehabilitation program, with a six-minute walk before and after",
          "Keep the open fires out of use permanently and heat his rooms another way; HEPA air cleaners in the rooms where he spends most time; check the air quality index daily and avoid outdoor exertion and city trips when it is 101 or more; a well-fitted N95 respirator on unavoidable alert days; walk away from main roads. The WHO 2021 guideline values for PM2.5 (5 ug/m3 annual, 15 ug/m3 over 24 hours) are a useful target for his indoor monitor",
          "Monitoring: Asthma Control Test, technique, adherence, and exposures at every visit; spirometry and FeNO at three months, then every one to two years; home peak flow to set action-plan zones; influenza, COVID-19, and RSV vaccines in the autumn and PCV20 now"
        ],
        "communication": "Discussed with Dr. Hartwell-Osei the same day; Mr. Locke agrees with the diagnosis and the plan and asked for a copy of the exposure advice for the household",
        "follow_up": "Primary care continues with Dr. Hartwell-Osei. I will review the three-month spirometry, and would see him again if he is not controlled on add-on tiotropium or has a flare needing oral corticosteroids"
      },
      "guideline_ids": [
        "GL-GINA-2025",
        "GL-GOLD-2025",
        "GL-NAEPP-2020",
        "GL-ATS-ERS-PFT-2022",
        "GL-ATS-RACE-2023",
        "GL-ATS-PR-2023",
        "GL-WHO-AQG-2021",
        "GL-ERS-AIR-2020",
        "GL-AIRNOW-AQI"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He has coughed for twenty years, and the city air leaves him unable to breathe; he wants to be able to do his work there",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic patient-centered concern echoing his documented letters.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wonders whether this is the consumption that his father and brother had",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern echoing his documented family history.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He asks whether the fire in his study is part of the problem",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic patient-centered concern about indoor smoke.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Cause of the cough and breathlessness established by the second visit",
        "status": "completed",
        "target_date": "2026-03-26",
        "outcome": "Asthma with persistent airflow limitation confirmed by spirometry, FeNO, eosinophils, DLCO, and CT; tuberculosis, alpha-1 antitrypsin deficiency, and heart failure excluded",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Asthma well controlled (Asthma Control Test 20 or more) with no flare needing oral corticosteroids",
        "status": "active",
        "target_date": "2027-03-31",
        "outcome": "ACT 21 at the last visit; one yellow-zone flare with a cold, managed by the action plan without oral corticosteroids",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic control goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "No indoor solid-fuel smoke and less outdoor pollution exposure",
        "status": "active",
        "target_date": "2027-03-31",
        "outcome": "Open fires out of use since intake; HEPA air cleaner in his study and bedroom; air quality alerts followed",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic exposure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Six-minute walk distance improved by at least 30 m after pulmonary rehabilitation",
        "status": "completed",
        "target_date": "2026-06-18",
        "outcome": "430 m before and 505 m after an eight-week program",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic rehabilitation goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Diagnostic workup: spirometry before and after bronchodilator, FeNO, DLCO, blood count with eosinophils, total IgE, alpha-1 antitrypsin, NT-proBNP, interferon-gamma release assay, chest X-ray, and CT of the chest if airflow limitation persists after bronchodilator; albuterol withheld for 6 hours before testing",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020",
          "GL-GOLD-2025",
          "GL-ATS-ERS-PFT-2022",
          "GL-ATS-RACE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic workup.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Exposure reduction from today: no open coal or wood fires in his rooms (electric or heat-pump heating instead); a portable HEPA air cleaner sized for his study and bedroom; daily check of the air quality index, with city trips and outdoor exertion avoided on alert days; a well-fitted N95 respirator on unavoidable high-pollution days; quieter routes away from main roads",
        "status": "completed",
        "guideline_ids": [
          "GL-WHO-AQG-2021",
          "GL-ERS-AIR-2020",
          "GL-AIRNOW-AQI",
          "GL-EPA-AIRCLEAN",
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic exposure plan, begun at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Pulmonology consultation on the diagnosis (asthma, COPD, or both), the need for CT, treatment, and pulmonary rehabilitation",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020",
          "GL-GOLD-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation, requested at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Shared decision on treatment: budesonide-formoterol 160/4.5 mcg as maintenance and reliever, two inhalations twice daily plus one as needed, no more than 12 a day; albuterol stopped; inhaler technique taught and checked at every visit; a written asthma action plan",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic shared decision.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "recorded_date": "2026-03-26"
      },
      {
        "id": "INT-005",
        "display": "Pulmonary rehabilitation: an eight-week, twice-weekly program of supervised exercise training and education, with a six-minute walk test before and after",
        "status": "completed",
        "guideline_ids": [
          "GL-GINA-2025",
          "GL-CMID-2026",
          "GL-ATS-PR-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic rehabilitation plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "recorded_date": "2026-03-26"
      },
      {
        "id": "INT-006",
        "display": "Vaccinations: pneumococcal conjugate vaccine PCV20 at the diagnosis visit; influenza, COVID-19, and RSV vaccines in the autumn; recombinant zoster vaccine",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Monitoring: Asthma Control Test, inhaler technique, adherence, reliever use, and exposures at every visit; spirometry and FeNO 3 months after starting treatment, then every 1 to 2 years; home peak flow diary",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic monitoring plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Add-on tiotropium 2.5 mcg soft-mist inhaler, two inhalations once daily, for persistent symptoms and airflow limitation on medium-dose budesonide-formoterol; written action plan updated with peak-flow zones from his personal best of 440 L/min",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic step-up decision.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "recorded_date": "2026-06-18"
      },
      {
        "id": "INT-009",
        "display": "After any flare: a review within one week, booked by the clinic when he calls or is seen for the flare",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-GINA-2025",
          "GL-NAEPP-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic post-flare plan, added after a missed post-flare review.",
          "author": "The Human Record generator",
          "created": "2026-11-06T09:00:00-05:00"
        },
        "recorded_date": "2026-10-22"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-GINA-2025",
        "title": "Global Strategy for Asthma Management and Prevention, 2025 update",
        "publisher": "Global Initiative for Asthma",
        "url": "https://ginasthma.org/reports/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-NAEPP-2020",
        "title": "2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group",
        "publisher": "National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33280709/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-GOLD-2025",
        "title": "Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report",
        "publisher": "Global Initiative for Chronic Obstructive Lung Disease",
        "url": "https://goldcopd.org/2025-gold-report/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-ATS-ERS-PFT-2022",
        "title": "Stanojevic S, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022;60(1):2101499 (PMID 34949706)",
        "publisher": "European Respiratory Society and American Thoracic Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34949706/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ATS-RACE-2023",
        "title": "Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004)",
        "publisher": "American Thoracic Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36973004/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ATS-PR-2023",
        "title": "Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline",
        "publisher": "American Thoracic Society (American Journal of Respiratory and Critical Care Medicine 2023;208(4):e7-e26)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37581410/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-WHO-AQG-2021",
        "title": "WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide",
        "publisher": "World Health Organization",
        "url": "https://www.who.int/publications/i/item/9789240034228",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ERS-AIR-2020",
        "title": "Carlsten C, et al. Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public. Eur Respir J 2020;55(6):1902056 (PMID 32241830)",
        "publisher": "European Respiratory Society",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32241830/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-AIRNOW-AQI",
        "title": "AQI Basics",
        "publisher": "United States Environmental Protection Agency (AirNow)",
        "url": "https://www.airnow.gov/aqi/aqi-basics/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-EPA-AIRCLEAN",
        "title": "Air Cleaners and Air Filters in the Home",
        "publisher": "United States Environmental Protection Agency",
        "url": "https://www.epa.gov/indoor-air-quality-iaq/air-cleaners-and-air-filters-home",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ACP-ARTI-2016",
        "title": "Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention",
        "publisher": "American College of Physicians (Annals of Internal Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/26785402/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-PSA-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-LUNG-2021",
        "title": "Lung Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening",
        "version_or_year": "2021"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the decision of asthma with persistent airflow limitation over COPD from non-tobacco exposures, the spirometry interpretation (GLI race-neutral equations, ATS/ERS 2022 bronchodilator criterion), the choice of medium-dose MART and add-on tiotropium, the CT indication, the exposure advice, and the management of the viral flare."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "The Stanford Encyclopedia of Philosophy, the Dictionary of National Biography (1893), Fox Bourne's two-volume biography (1876) quoting his letters and Lady Masham's account, Williams (2006), and Anstey and Principe (2011) logged. The de Beer edition of the correspondence, Woolhouse's biography, Dewhurst's medical biography, and the Bodleian manuscripts could not be read."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No behavioral-health content; PHQ-2 negative at both screens."
    }
  }
}
